Lincoln Pharmaceuticals Ltd
Business
Business News
Press Release
Lincoln Pharmaceuticals Ltd reports 57.85% rise in the Standalone Net Profit at ₹ 23.74 crore in Q2 FY23
Mr . Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd Highlights:- · Total Income from operation in Q2 FY23 at ₹ 146.30 crore, up 12.5% from ₹ 130.00 crore in Q1 FY23; · During the year, company got an approval from WHO-GMP for Tablet Capsule, dry-powder Suspension products at Cephalosporin plant. · Approved dividend of ₹ […]
Read More